Nan Bi

19PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 11, 2026
Radiation-free or Chemo-free: Rethinking the Best Strategy for PD-L1-High, Unresectable Stage III NSCLC.

|Sep 09, 2026
Early stage nonsmall cell lung cancer: Toward a risk-adaptive paradigm in the era of biologic precision.

|May 14, 2026
The Addition of Concurrent Immune Checkpoint Inhibitors for Chemoradiotherapy With Consolidative Immune Checkpoint Inhibitors in Unresectable Cancers: A Systematic Review and Meta-Analysis.

|Apr 10, 2026
Comparing the Prognosis of Non-Small Cell Lung Cancer Patients Who Did Not Undergo Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy: A Retrospective Study.

Zhenghui Ma, Yuqi Wu, Guangqian Ji

|Feb 06, 2026
Interpretable deep learning model of circulating genomics for quantitative survival prediction in advanced non-small cell lung cancer.

Yu Wang, Yi-Tong Li, Ming-Hao Wang

|Jan 06, 2026
PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer.

Yu Wang, Yong-Bo Xiang, Xiao-Wei Chen

Pageof 4

Frequent Collaborators

3 joint publications

Luhua Wang

2 joint publications

Lei Deng

2 joint publications

Yuqi Wu

2 joint publications

Yibo Gao